Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/26 16:23 | 7/16/26 | CDNA | Health | Health | Medical Laboratories | Hanna John Walter Jr | CA | DO | P,CEO | 8 | S.dm | -7,541 | 31.11 | 0 | -242 | 676 | D | |||||||||||||||
7/17/26 16:22 | 7/16/26 | CDNA | Health | Health | Medical Laboratories | Valantine Hannah | CA | D | 3 | S.d | -1,523 | 29.59 | 0 | -51 | 39 | D | ||||||||||||||||
5/18/26 16:05 | 5/14/26 | CDNA | Health | Health | Medical Laboratories | Torres Arthur A | CA | D | 1 | S.m | -215 | 20.31 | 0 | -11 | 39 | D | ||||||||||||||||
5/6/26 16:05 | 5/5/26 | CDNA | Health | Health | Medical Laboratories | Novack Jeffrey Adam | CA | O | Secretar | 7 | S | -419 | 17.88 | 0 | -23 | 127 | D | |||||||||||||||
7/10/25 16:04 | 7/7/25 | CDNA | Health | Health | Medical Laboratories | Maag Peter | CA | D | 3 | S | -607 | 18.24 | 0 | -33 | 319 | D | ||||||||||||||||
6/13/25 17:06 | 6/11/25 | CDNA | Health | Health | Medical Laboratories | Hagstrom William A | CA | D | 2 | S.d | -909 | 18.41 | 0 | -49 | 54 | D | ||||||||||||||||
5/14/25 17:18 | 5/12/25 | CDNA | Health | Health | Medical Laboratories | Cournoyer Christine | CA | D | 2 | S.d | -701 | 15.29 | 0 | -46 | 37 | D | ||||||||||||||||
4/9/25 16:31 | 4/7/25 | CDNA | Health | Health | Medical Laboratories | Jain Abhishek | CA | O | CFO | 1 | S | -5 | 17.72 | 0 | 0 | 0 | 337 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |